How to Successfully Generate an Alternative Approach to a Thorough QT Study: GLPG1972 as an Example Clin Pharmacol Ther. 2023 Feb;113(2):310-320 Meyer C, Dierick I, Gauderat G, Langenhorst J, Sarr C, Leroux E, Chenel M, Fouliard S, Passier P. CVJournalMIDDPharmacometricsProgram strategies and efficienciesRegulatory interactions Pharmetheus Affiliates Senior Consultant & Team Leader Jurgen Langenhorst See bio Principal Consultant & Team Leader Céline Sarr See bio Chief Research Officer Marylore Chenel See bio
